iBio (IBIO) Other financing activities (2014 - 2026)

iBio (IBIO) has 11 years of Other financing activities data on file, last reported at $1.7 million in Q1 2026.

• On a quarterly basis, Other financing activities rose 1612.92% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 79.8% decrease from a year earlier, with the FY2025 full-year figure at $113.0, down 100.0% from the prior year.
• Other financing activities for Q1 2026 stood at $1.7 million, down from $3.0 million in the prior quarter.
• Over the last five years, Other financing activities for IBIO reached as high as $18.1 million in Q4 2024 and fell as low as -$129887.0 in Q2 2025.
• Historically, Other financing activities has averaged $3.3 million across 4 years, with a median of $1.7 million in 2026.
• Across the five-year window, Other financing activities plunged 102.91% in 2025 and jumped 1612.92% in 2026, its largest moves.
• Year by year, Other financing activities stood at $2.2 million in 2023, then soared by 726.54% to $18.1 million in 2024, then plunged by 83.39% to $3.0 million in 2025, then plunged by 43.33% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $1.7 million in Q1 2026, $3.0 million in Q4 2025, and $30.0 in Q3 2025.